References
Wettergren A, Peterson H, Orskov C, Christiansen J, Sheikh SP, Holst JJ. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-Cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand J Gastroenterol 1994;29:501–5.
Jarrous C, Carles-Bonnet C, Niel H, Sabatier R, Audousset-Puech MP, Blache P, et al. Inhibition of gastric acid secretion by oxyntomodulin and its 19-37 fragment in the conscious rat. Am J Physiol 1993;264:G816–23.
O’Halloran DJ, Nikou GC, Kreymann MB, Ghatei MA, Bloom SR. Glucagon-like peptide-1 (7-36)-NH2: a physiological inhibitor of gastric acid secretion in man. J Endocrinol 1990;126:169–73.
Gompertz RHK, Michalowski A, Man WK, Spencer J, Baron JH. Duodenal ulcer: a model of impaired mucosal defence. Gut 1992;33:1044–9.
Sanders MJ, Soil A. Characterization of receptors regulating secretory function in the fundic mucosa. Ann Rev Physiol 1986;48:89–101.
Lloyd KC, Wang J, Aurang K, Gronhed P, Coy DH, Walsh JH. Activation of somatostatin receptor subtype-2 inhibits acid secretion in rats. Am J Physiol 1995;268:G102–6.
Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W. Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1[7-36]amide infused at near physiological concentration on pentagastrin-stimulated gastric acid secretion in normal human subjects. Digestion 1992;52:214–21.
Schubert ML. The effect of vasoactive intestinal polypeptide on gastric acid secretion is predominantly mediated by somatostatin. Gastroenterology 1991;100:1195–200.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ben-Hamida, A., Man, W.K. & Spencer, J. The effect of some gastrointestinal peptides on pentagastrin-stimulated acid secretion and oxyntic mucosal histamine in rats. Inflamm. Res. 45 (Suppl 1), S46–S47 (1996). https://doi.org/10.1007/BF03354082
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03354082